FDAFDA · Food and drugs·Recall number D-0280-2022
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Published December 22, 2021 · Recall initiated: October 12, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Teligent Pharma, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.